ASH Clinical Practice Guidelines on Acute Myeloid Leukemia in Older Adults
The ASH Guidelines on Acute Myeloid Leukemia (AML) in Older Adults were published in 2020. These guidelines are intended to help older adults with AML and their healthcare providers make critical care decisions including if and how to proceed with cancer treatment and the need for blood transfusions for those in hospice care. In 2023, ASH will form a guideline panel to update the 2020 guidelines. A methodology team will conduct systematic reviews of new evidence, and the panel will revise previous recommendations.
In February 2022, these guidelines were reviewed by an expert work group convened by ASH. Following this review, the ASH Committee on Quality agreed to revise these guidelines. A guideline update is under way.
Access the full guidelines on the Blood Advances website:
Learn more about the development process behind the AML guidelines.
Guideline Implementation Tools and Resources
In 2022, ASH agreed to revise these guidelines. Derivative resources will be published with revised guidelines.
The ASH Clinical Practice Guidelines App provides easy access to every recommendation from all guidelines published by ASH, including rationale for each recommendation, benefits and harms associated with each recommended course of action, and links to the complete evidence-to-decision tables used to develop the recommendations. This app is also available via web interface.
ASH Pocket Guides App
The ASH Pocket Guides App includes all of ASH’s pocket guides. This app is also available via web interface.